Cannapharmarx Inc CPMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.02
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $473,145.59
- Volume/Avg
- 1.1 Mil / 3.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cannapharmarx Inc is involved in the cannabis sector. The company negotiates, acquires, and develops various cannabis cultivation projects throughout Canada. Its three projects include the Hanover Project; the Great Northern Project; and the Acquisition of Sunniva Medical.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 6
- Website
- https://www.cannapharmarx.com
Valuation
|
Metric
|
CPMD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CPMD
Financial Strength
|
Metric
|
CPMD
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | −2.72 |
Quick Ratio
CPMD
Profitability
|
Metric
|
CPMD
|
|---|---|
Return on Assets (Normalized) | −130.11% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CPMD
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Wxk | $84.8 Bil | |
MKKGY
| Merck KGaA ADR | Mcyjqsm | $66.6 Bil | |
HLN
| Haleon PLC ADR | Zbbw | $37.8 Bil | |
VTRS
| Viatris Inc | Jsz | $11.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lghqq | $11.5 Bil | |
CTLT
| Catalent Inc | Lvhjqrk | $6.7 Bil | |
PRGO
| Perrigo Co PLC | Hqvk | $4.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Cmk | $3.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pgwthd | $3.0 Bil | |
GTBIF
| Green Thumb Industries Inc | Pgmj | $2.7 Bil |